Baker Bros. Advisors LP Trevena Inc Transaction History

Baker Bros. Advisors LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2018 Nov 14, 2018	SELL	$1.39 - $2.25 $1.32 Million - $2.14 Million	-950,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.22 - $2.79 $2.11 Million - $2.65 Million	950,000	950,000 $2.42 Million

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.